Bill Text: IA HF2099 | 2023-2024 | 90th General Assembly | Enrolled
Bill Title: A bill for an act relating to the regulation of pharmacy benefits managers. (Formerly HSB 536.) Effective date: 07/01/2024.
Spectrum: Committee Bill
Status: (Passed) 2024-05-01 - Signed by Governor. H.J. 936. [HF2099 Detail]
Download: Iowa-2023-HF2099-Enrolled.html
House
File
2099
-
Enrolled
House
File
2099
AN
ACT
RELATING
TO
THE
REGULATION
OF
PHARMACY
BENEFITS
MANAGERS.
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
Section
1.
Section
510B.1,
subsection
10,
paragraph
b,
Code
2024,
is
amended
to
read
as
follows:
b.
National
average
drug
acquisition
cost.
Sec.
2.
Section
510B.4,
subsection
1,
Code
2024,
is
amended
to
read
as
follows:
1.
A
pharmacy
benefits
manager
shall
exercise
good
faith
and
fair
dealing
in
the
performance
of
the
pharmacy
benefits
manager’s
contractual
obligations
toward
a
third-party
payor
or
a
pharmacy
.
Sec.
3.
NEW
SECTION
.
510B.4A
Retaliation
prohibited.
A
pharmacy
benefits
manager
shall
not
retaliate
against
a
pharmacy
based
on
the
pharmacy’s
exercise
of
any
right
or
remedy
under
this
chapter,
including
but
not
limited
to
filing
a
complaint
with
the
commissioner
or
cooperating
with
the
commissioner
pursuant
to
the
commissioner’s
authority
under
this
chapter.
Retaliation
prohibited
by
this
section
shall
include
but
is
not
limited
to
all
of
the
following:
1.
Terminating
or
refusing
to
renew
a
contract
with
the
pharmacy.
2.
Subjecting
the
pharmacy
to
increased
audits.
3.
Withholding
or
failing
to
promptly
pay
the
pharmacy
any
money
owed
by
the
pharmacy
benefits
manager
to
the
pharmacy.
House
File
2099,
p.
2
Sec.
4.
Section
510B.7,
Code
2024,
is
amended
to
read
as
follows:
510B.7
Pharmacy
networks
fees
.
A
pharmacy
benefits
manager
shall
not
assess,
charge,
or
collect
any
form
of
remuneration
that
passes
from
a
pharmacy
or
a
pharmacist
in
a
pharmacy
network
to
the
pharmacy
benefits
manager
including
but
not
limited
to
claim
processing
fees,
performance-based
fees,
network
participation
fees,
or
accreditation
fees.
Sec.
5.
Section
510B.8A,
subsection
2,
paragraph
b,
Code
2024,
is
amended
to
read
as
follows:
b.
Update
the
maximum
allowable
cost
list
within
seven
calendar
days
from
the
date
of
an
increase
of
ten
percent
or
more
in
the
pharmacy
national
average
drug
acquisition
cost
of
a
prescription
drug
on
the
list
by
one
or
more
wholesale
distributors
doing
business
in
the
state
.
Sec.
6.
Section
510C.2,
subsection
2,
paragraph
a,
unnumbered
paragraph
1,
Code
2024,
is
amended
to
read
as
follows:
A
pharmacy
benefits
manager
shall
provide
the
information
pursuant
to
subsection
1
to
the
commissioner
in
a
format
approved
by
the
commissioner
that
does
not
directly
or
indirectly
publicly
disclose
any
of
the
following:
______________________________
PAT
GRASSLEY
Speaker
of
the
House
______________________________
AMY
SINCLAIR
President
of
the
Senate
I
hereby
certify
that
this
bill
originated
in
the
House
and
is
known
as
House
File
2099,
Ninetieth
General
Assembly.
______________________________
MEGHAN
NELSON
Chief
Clerk
of
the
House
Approved
_______________,
2024
______________________________
KIM
REYNOLDS
Governor
